Pharmaceutical Production
Scaling complex biological processes through Digital Twins and Quality by Design (QbD).
Engineering Yield and Compliance
Modern pharmaceutical manufacturing is shifting from batch processing to continuous, data-driven production. Malgukke provides the HPC architectures and Edge Computing necessary to simulate bioreactors in real-time and ensure rigorous quality standards through computational modeling.
Digital Twins
Leveraging high-fidelity process simulations to maximize yields and predict outcomes before physical production begins.
Quality by Design (QbD)
Implementing computer-aided quality assurance to move from "testing for quality" to "designing for quality."
Operational Logic: Simulation to Market
| Production Focus | Computational Action | Industrial ROI |
|---|---|---|
| Fermentation Yield | Computational Fluid Dynamics (CFD) on GPU clusters. | 20% Increase in Batch Output. |
| Regulatory Filing | Monte Carlo simulations for design space validation. | Accelerated FDA/EMA Approval Cycles. |
Voices from the Field
Researchers and industry leaders driving continuous manufacturing and digital quality assurance share their insights in recent interviews:
Johannes Khinast
CEO & Scientific Director, RCPE, Graz
On how flexible, continuous manufacturing can reduce Europe's dependence on Asian API production.
Read interviewJohannes Khinast
RCPE, Graz
On why continuous manufacturing can turn a full production batch around within a single day.
Read articleJohannes Khinast & Thomas Klein
Scientific Director & Business Director, RCPE
On why Quality by Design (QbD) principles reshaped how pharmaceutical processes are engineered and filed.
Read interviewSandeep Kedia
Senior Technology Fellow, NIIMBL
On new technology projects combining real-time process analytics with AI-driven process optimization.
Read articleInstitutes Leading Pharmaceutical Manufacturing Innovation
Malgukke architectures are built to support the data infrastructure needs of leading biopharma manufacturing institutions: